Author

Anne C. R. Robinson

Observed names: A Robinson, A. C. R. Robinson, A. C. Robinson, A. Robinson, A.C. Robinson, A.C.R. Robinson, ANNE C. R. ROBINSON, Anne C R Robinson, Anne C. Robinson, Anne Robinson

Institutions: Institute of Cancer Research, Royal Marsden Hospital

Observed institutions: Guy's Hospital, University of Leeds, Institute of Cancer Research, Royal Free London NHS Foundation Trust, Trinity College Dublin, Queen Elizabeth Hospital Birmingham, Royal Devon & Exeter NHS Foundation Trust, Norfolk and Norwich University Hospital, Royal Surrey County Hospital, Chelsea and Westminster Hospital NHS Foundation Trust, Southend University Hospital NHS Foundation Trust, The Royal Free Hospital, Churchill Hospital, Royal Devon and Exeter Hospital, Cancer Research UK, Newcastle upon Tyne Hospitals NHS Foundation Trust, Nottingham City Hospital, Southend Hospital, St. Luke's Hospital, Royal Marsden Hospital, Newcastle upon Tyne Hospital, Cancer Research UK Manchester Institute, Centre Oscar Lambret, The Christie Hospital, Chelsea and Westminster Hospital, Velindre Cancer Centre, St. James's Hospital, Addenbrooke's Hospital, Ipswich Hospital, Essex County Hospital, Cardiff University, University of Birmingham, Medical Research Council

ORCID: 0009-0009-8177-1117

Observed ORCID: 0009-0009-8177-1117

OpenAlex ID: A5109934981

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

2020 · Sandra M Swain, David Miles, et al. · The Lancet Oncology · 915

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

2017 · Miguel Martin, Frankie A Holmes, et al. · The Lancet Oncology · 585

aTTom: Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6,953 women with early breast cancer.

2013 · Richard G. Gray, Daniel Rea, et al. · Journal of Clinical Oncology · 451

Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial

2013 · Stephen RD Johnston, Lucy S Kilburn, et al. · The Lancet Oncology · 274

PDF

Oral Sodium Clodronate for Nonmetastatic Prostate Cancer--Results of a Randomized Double-Blind Placebo-Controlled Trial: Medical Research Council PR04 (ISRCTN61384873)

2007 · M. D. Mason, M. R. Sydes, et al. · JNCI Journal of the National Cancer Institute · 106

long-term follow-up of anglian germ cell cancer group surveillance versus patients with stage 1 nonseminoma treated with adjuvant chemotherapy

2004 · R.T.D Oliver, J Ong, et al. · Urology · 101

aTTom: Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6,953 women with early breast cancer.

2013 · Richard G. Gray, Daniel Rea, et al. · Journal of Clinical Oncology · 97

A novel continuous infusional 5-fluorouracil-based chemotherapy regimen compared with conventional chemotherapy in theneo-adjuvant treatment of early breast cancer: 5 year results of the TOPIC trial

2004 · I.E. Smith, R.P. A’Hern, et al. · Annals of Oncology · 60

PDF

Adjuvant chemotherapy in older women (ACTION) study – what did we learn from the pilot phase?

2011 · R Leonard, R Ballinger, et al. · British Journal of Cancer · 49

PDF

Neoadjuvant vinorelbine/epirubicin (VE) versus standard adriamycin/cyclophosphamide (AC) in operable breast cancer: analysis of response and tolerability in a randomised phase III trial (TOPIC 2)

2005 · S. Chua, I.E. Smith, et al. · Annals of Oncology · 40

A phase II trial of goserelin (Zoladex) in relapsed epithelial ovarian cancer

1992 · MJ Lind, BMJ Cantwell, et al. · British Journal of Cancer · 30

PDF

Hypergonadotrophic hypogonadism in classical galactosaemia: evidence for defective oognesis. Case report

1984 · ANNE C. R. ROBINSON, C. J. DOCKERAY, et al. · BJOG An International Journal of Obstetrics & Gynaecology · 30

HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer

2022 · Milana A. Bergamino, Elena López-Knowles, et al. · EBioMedicine · 23

Evaluation of response following irradiation of juvenile angiofibromas

1989 · Anne C. R. Robinson, G. G. Khoury, et al. · British Journal of Radiology · 18

Optimal Management of Cancer Treatment-Induced Bone Loss

2011 · Karen Tipples, Anne Robinson · Drugs & Aging · 16

Modified de Gramont with oxaliplatin in the first-line treatment of advanced colorectal cancer

2003 · M S Braun, F Adab, et al. · British Journal of Cancer · 16

PDF

Analysis of rare disruptive germline mutations in 2135 enriched BRCA-negative breast cancers excludes additional high-impact susceptibility genes

2022 · C. Loveday, A. Garrett, et al. · Annals of Oncology · 15

PDF

Changes in scalp hair after cancer chemotherapy

1989 · Anne Robinson, William Jones · European Journal of Cancer and Clinical Oncology · 15

No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort study

2008 · KConFab, Timothy R. Rebbeck, et al. · Breast Cancer Research and Treatment · 12

Angioneurotic oedema and urticaria induced by hyoscine butylbromide

1982 · Anne C R Robinson, Mary Teeling · Postgraduate Medical Journal · 11

PDF

Idiopathic midline destructive disease—case report and review of the literature

1984 · Anne C. R. Robinson, Ian Fraser, et al. · Postgraduate Medical Journal · 10

Optimising Care of Elderly Breast Cancer Patients: a Challenging Priority

2008 · K. Tipples, A. Robinson · Clinical Oncology · 9

Percutaneous nephrostomy: Its value in obstructive uropathy complicating carcinoma of cervix uterus

1990 · S. Chan, A.C.R. Robinson, et al. · Clinical Oncology · 8

Circulating reproductive hormones and hypothalamic oestradiol and progestin receptors in infertile Zucker rats

1989 · E. M. Whitaker, A. C. Robinson · Journal of Endocrinology · 8

Lymphoma of uterine cervix.

1989 · G G Khoury, A Robinson · PubMed · 8

Works count: 42

Citation count: 2,939

H-index: 16

I10-index: 21